{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:21:41Z","timestamp":1772025701823,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To explore the function of fibulin-3 in cervical carcinoma malignant cell growth and metastasis, fibulin-3 expression in normal cervical tissue, cervical intraepithelial neoplasia (CIN), and cervical carcinoma were evaluated by immunohistochemistry. Quantitative real-time-polymerase chain reaction, western blotting, and immunocytochemistry were performed to assess the expression of fibulin-3 at mRNA and protein levels in different invasive clone sublines. Fibulin-3 shRNA and fibulin-3 cDNA were used to transfect the strongly and weakly invasive clone sublines. Using <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> functional assays, we investigated the effects of down-regulating and up-regulating fibulin-3 expression on the proliferation and invasion of different clone sublines. Epithelial mesenchymal transition (EMT) and its signaling pathways PI3K\/AKT and ERK were studied carefully in lentiviral transfection systems. Fibulin-3 was upregulated in cervical carcinoma, and its overexpression was significantly related with malignant phenotype and poor prognosis of cervical carcinoma. Fibulin-3 promoted cervical cancer cell invasive capabilities by eliciting EMT and activating the PI3K-Akt-mTOR signal transduction pathway. Fibulin-3 could facilitate the process of cervical cancer development. The results presented here will help develop novel prognostic factors and possible therapeutic options for patients with cervical cancer.<\/jats:p>","DOI":"10.1038\/s41598-018-28906-9","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T09:10:29Z","timestamp":1531127429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["RETRACTED ARTICLE: Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo"],"prefix":"10.1038","volume":"8","author":[{"given":"Juan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changzhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,13]]},"reference":[{"key":"28906_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4103\/0971-5851.195751","volume":"37","author":"S Bobdey","year":"2016","unstructured":"Bobdey, S., Sathwara, J., Jain, A. & Balasubramaniam, G. Burden of cervical cancer and role of screening in India. Indian J Med Paediatr Oncol. 37, 278\u2013285 (2016).","journal-title":"Indian J Med Paediatr Oncol."},{"key":"28906_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brachy.2016.10.007","volume":"16","author":"G Suneja","year":"2017","unstructured":"Suneja, G. et al. American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries. Brachytherapy. 16, 85\u201394 (2017).","journal-title":"Brachytherapy."},{"key":"28906_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/ijc.30695","volume":"141","author":"AK Mezei","year":"2017","unstructured":"Mezei, A. K. et al. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review. Int J Cancer. 141, 437\u2013446 (2017).","journal-title":"Int J Cancer."},{"issue":"3","key":"28906_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.exer.2009.09.018","volume":"90","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. & Marmorstein, L. Y. Focus on molecules: fibulin-3 (EFEMP1). Exp Eye Res. 90(3), 374\u2013375 (2010).","journal-title":"Exp Eye Res."},{"key":"28906_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrm1130","volume":"4","author":"R Timpl","year":"2003","unstructured":"Timpl, R., Sasaki, T., Kostka, G. & Chu, M. L. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol. 4, 479\u2013489 (2003).","journal-title":"Nat Rev Mol Cell Biol."},{"key":"28906_CR6","first-page":"11805","volume":"282","author":"N Kobayashi","year":"2007","unstructured":"Kobayashi, N. et al. A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization. J Biol Chem. 282, 11805\u201311816 (2007).","journal-title":"Biochemical characterization, binding interactions, and tissue localization. J Biol Chem."},{"issue":"11","key":"28906_CR7","doi-asserted-by":"publisher","first-page":"e78783","DOI":"10.1371\/journal.pone.0078783","volume":"8","author":"J Chen","year":"2013","unstructured":"Chen, J., Wei, D., Zhao, Y., Liu, X. & Zhang, J. Overexpression of EFEMP1 Correlates with Tumor Progression and Poor Prognosis in Human Ovarian Carcinoma. PLoS One. 8(11), e78783 (2013).","journal-title":"PLoS One."},{"issue":"30","key":"28906_CR8","doi-asserted-by":"publisher","first-page":"47938","DOI":"10.18632\/oncotarget.10296","volume":"7","author":"X Yin","year":"2016","unstructured":"Yin, X. et al. EFEMP1 promotes ovarian cancer cell growth, invasion and metastasis via activated the AKT pathway. Oncotarget. 7(30), 47938\u201347953 (2016).","journal-title":"Oncotarget."},{"issue":"1","key":"28906_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06353-2","volume":"7","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt\/\u03b2-catenin signaling pathway. Sci Rep. 7(1), 6215 (2017).","journal-title":"Sci Rep."},{"issue":"2","key":"28906_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1158\/1541-7786.MCR-08-0132","volume":"7","author":"H Seeliger","year":"2009","unstructured":"Seeliger, H. et al. EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma. Mol Cancer Res. 7(2), 189\u2013198 (2009).","journal-title":"Mol Cancer Res."},{"issue":"11","key":"28906_CR11","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1158\/1541-7786.MCR-09-0207","volume":"7","author":"B Hu","year":"2009","unstructured":"Hu, B., Thirtamara-Raiamani, K. K., Sim, H. & Viapiano, M. S. Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion. Mol Cancer Res. 7(11), 1756\u20131770 (2009).","journal-title":"Mol Cancer Res."},{"issue":"6","key":"28906_CR12","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.3892\/or.2016.4733","volume":"35","author":"CY Dou","year":"2016","unstructured":"Dou, C. Y. et al. EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1\/2 activity. Oncol Rep. 35(6), 3489\u20133495 (2016).","journal-title":"Oncol Rep."},{"issue":"8","key":"28906_CR13","doi-asserted-by":"publisher","first-page":"e70511","DOI":"10.1371\/journal.pone.0070511","volume":"8","author":"R Luo","year":"2013","unstructured":"Luo, R. et al. Decrease of fibulin-3 in hepatocellular carcinoma indicates poor prognosis. PLoS One. 8(8), e70511 (2013).","journal-title":"PLoS One."},{"issue":"6","key":"28906_CR14","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.3892\/mmr.2014.2135","volume":"9","author":"XJ Zhu","year":"2014","unstructured":"Zhu, X. J., Liu, J., Xu, X. Y., Zhang, C. D. & Dai, D. Q. Novel tumor-suppressor gene epidermal growth factor-containing fibulin-like extracellular matrix protein 1 is epigenetically silenced and associated with invasion and metastasis in human gastric cancer. Mol Med Rep. 9(6), 2283\u20132292 (2014).","journal-title":"Mol Med Rep."},{"issue":"8","key":"28906_CR15","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1093\/carcin\/bgu023","volume":"35","author":"X Chen","year":"2014","unstructured":"Chen, X. et al. Fibulin-3 suppresses Wnt\/\u03b2-catenin signaling and lung cancer invasion. Carcinogenesis. 35(8), 1707\u20131716 (2014).","journal-title":"Carcinogenesis."},{"issue":"30","key":"28906_CR16","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1038\/onc.2013.373","volume":"33","author":"IG Kim","year":"2014","unstructured":"Kim, I. G. et al. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+\u2009lung cancer stem cells through IGF1R signaling. Oncogene. 33(30), 3908\u20133917 (2014).","journal-title":"Oncogene."},{"issue":"6","key":"28906_CR17","doi-asserted-by":"publisher","first-page":"e67458","DOI":"10.1371\/journal.pone.0067458","volume":"8","author":"T Yang","year":"2013","unstructured":"Yang, T. et al. Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma. PLoS One. 8(6), e67458 (2013).","journal-title":"PLoS One."},{"issue":"4","key":"28906_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/path.2776","volume":"222","author":"CF Hwang","year":"2010","unstructured":"Hwang, C. F. et al. Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity. J Pathol. 222(4), 367\u2013379 (2010).","journal-title":"J Pathol."},{"issue":"1","key":"28906_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-464","volume":"12","author":"J Chen","year":"2012","unstructured":"Chen, J. et al. Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis. BMC Cancer. 12(1), 464 (2012).","journal-title":"BMC Cancer."},{"key":"28906_CR20","doi-asserted-by":"publisher","first-page":"11091","DOI":"10.1007\/s13277-014-2424-9","volume":"35","author":"XS Yang","year":"2014","unstructured":"Yang, X. S. et al. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients. Tumor Biol. 35, 11091\u201311095 (2014).","journal-title":"Tumor Biol."},{"issue":"16","key":"28906_CR21","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1158\/0008-5472.CAN-16-1971","volume":"76","author":"A Albini","year":"2016","unstructured":"Albini, A. Extracellular Matrix Invasion in Metastases and Angiogenesis: Commentary on the Matrigel \u201cChemoinvasion Assay\u201d. Cancer Res. 76(16), 4595\u20134597 (2016).","journal-title":"Cancer Res."},{"key":"28906_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2017.01.029","volume":"391","author":"RL Pearlman","year":"2017","unstructured":"Pearlman, R. L., Montes de Oca, M. K., Pal, H. C. & Afaq, F. Potential therapeutic targets of epithelial-mesenchymal transition in melanoma. Cancer Lett. 391, 125\u2013140 (2017).","journal-title":"Cancer Lett."},{"issue":"3","key":"28906_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ygyno.2009.12.016","volume":"117","author":"S En-lin","year":"2010","unstructured":"En-lin, S., Sheng-guo, C. & Hua-qiao, W. The expression of EFEMP1 in cervical carcinoma and its relationship with prognosis. Gynecol Oncol. 117(3), 417\u2013422 (2010).","journal-title":"Gynecol Oncol."},{"issue":"1","key":"28906_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ygyno.2010.11.004","volume":"121","author":"EL Song","year":"2011","unstructured":"Song, E. L. et al. EFEMP1 expression promotes angiogenesis and accelerates the growth of cervical cancer in vivo. Gynecol Oncol. 121(1), 174\u2013180 (2011).","journal-title":"Gynecol Oncol."},{"issue":"7","key":"28906_CR25","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/ijc.24108","volume":"124","author":"A Sadr-Nabavi","year":"2009","unstructured":"Sadr-Nabavi, A. et al. Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. Int J Cancer. 124(7), 1727\u20131735 (2009).","journal-title":"Int J Cancer."},{"issue":"45","key":"28906_CR26","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1038\/onc.2015.13","volume":"34","author":"H Tian","year":"2015","unstructured":"Tian, H., Liu, J., Chen, J., Gatza, M. L. & Blobe, G. C. Fibulin-3 is a novel TGF-\u03b2 pathway inhibitor in the breast cancer. Oncogene. 34(45), 5635\u20135647 (2015).","journal-title":"Oncogene."},{"issue":"18","key":"28906_CR27","doi-asserted-by":"publisher","first-page":"25712","DOI":"10.18632\/oncotarget.8263","volume":"7","author":"T Yang","year":"2016","unstructured":"Yang, T. et al. EFEMP1 is repressed by estrogen and inhibits the epithelial-mesenchymal transition via Wnt\/\u03b2-catenin signaling in endometrial carcinoma. Oncotarget. 7(18), 25712\u201325725 (2016).","journal-title":"Oncotarget."},{"issue":"11","key":"28906_CR28","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 19(11), 1423\u20131437 (2013).","journal-title":"Nat Med."},{"issue":"3","key":"28906_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 15(3), 178\u2013196 (2014).","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"1","key":"28906_CR30","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3390\/cancers30100716","volume":"3","author":"D Kong","year":"2011","unstructured":"Kong, D., Li, Y., Wang, Z. & Sarkar, F. H. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins? Cancers (Basel). 3(1), 716\u2013729 (2011).","journal-title":"Cancers (Basel)."},{"issue":"7","key":"28906_CR31","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.2174\/18715206113139990078","volume":"13","author":"A Ahmad","year":"2013","unstructured":"Ahmad, A. et al. Targeted regulation of PI3K\/Akt\/mTOR\/NF-\u03baB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy. Anticancer Agents Med Chem. 13(7), 1002\u20131013 (2013).","journal-title":"Anticancer Agents Med Chem."}],"updated-by":[{"DOI":"10.1038\/s41598-023-38389-y","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"record-id":"45980"},{"DOI":"10.1038\/s41598-023-38389-y","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28906-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28906-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28906-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T18:08:04Z","timestamp":1689271684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28906-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,13]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["28906"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-28906-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,13]]},"assertion":[{"value":"14 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-023-38389-y","URL":"https:\/\/doi.org\/10.1038\/s41598-023-38389-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10594"}}